The Leadership Team at Cardiff Oncology drives the strategic direction and decision-making necessary to advance the company’s mission of developing innovative cancer treatments. Comprising key executives such as the CEO, CFO, and CSO, this team oversees regulatory strategies, financial management, and scientific research initiatives, ensuring that the development of onvansertib and other therapeutics aligns with the company’s goals of improving patient outcomes and addressing critical medical needs in oncology.
View all